DK131878A - Fremgangsmaade til fremstilling af peptider og mellemprodukt til anvendelse ved fremgangsmaaden - Google Patents

Fremgangsmaade til fremstilling af peptider og mellemprodukt til anvendelse ved fremgangsmaaden

Info

Publication number
DK131878A
DK131878A DK131878A DK131878A DK131878A DK 131878 A DK131878 A DK 131878A DK 131878 A DK131878 A DK 131878A DK 131878 A DK131878 A DK 131878A DK 131878 A DK131878 A DK 131878A
Authority
DK
Denmark
Prior art keywords
procedure
preparing peptides
intermediate use
peptides
preparing
Prior art date
Application number
DK131878A
Other languages
English (en)
Inventor
W W Vale
J E F Rivier
M R Brown
Original Assignee
Salk Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst filed Critical Salk Inst
Publication of DK131878A publication Critical patent/DK131878A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK131878A 1977-03-28 1978-03-22 Fremgangsmaade til fremstilling af peptider og mellemprodukt til anvendelse ved fremgangsmaaden DK131878A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/781,580 US4105603A (en) 1977-03-28 1977-03-28 Peptides which effect release of hormones

Publications (1)

Publication Number Publication Date
DK131878A true DK131878A (da) 1978-09-29

Family

ID=25123228

Family Applications (1)

Application Number Title Priority Date Filing Date
DK131878A DK131878A (da) 1977-03-28 1978-03-22 Fremgangsmaade til fremstilling af peptider og mellemprodukt til anvendelse ved fremgangsmaaden

Country Status (19)

Country Link
US (1) US4105603A (da)
JP (1) JPS53130687A (da)
AT (1) AT366026B (da)
AU (1) AU519122B2 (da)
BE (1) BE865380A (da)
CA (1) CA1102314A (da)
CH (1) CH639361A5 (da)
DE (1) DE2813327A1 (da)
DK (1) DK131878A (da)
ES (1) ES468241A1 (da)
FI (1) FI780907A (da)
FR (1) FR2385688A1 (da)
GB (1) GB1564191A (da)
IE (1) IE46862B1 (da)
IT (1) IT1105152B (da)
LU (1) LU79320A1 (da)
NL (1) NL7803289A (da)
SE (1) SE446190B (da)
ZA (1) ZA781599B (da)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211693A (en) * 1977-09-20 1980-07-08 The Salk Institute For Biological Studies Peptides with para-substituted phenylalanine
US4185010A (en) * 1978-12-12 1980-01-22 American Home Products Corporation Nonapeptides
US4225472A (en) * 1979-05-29 1980-09-30 American Home Products Corporation Truncated somatostatin analogs
USRE30548E (en) * 1979-08-31 1981-03-17 The Salk Institute For Biological Studies Peptides which effect release of hormones
EP0029579B1 (en) * 1979-11-27 1983-02-16 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
FR2523125A1 (fr) * 1982-03-08 1983-09-16 Sanofi Sa Analogues de la somatostatine a activite biologique modifiee et medicaments en contenant
US4428942A (en) 1982-05-17 1984-01-31 The Salk Institute For Biological Studies Analogs of somatostatin
US4443368A (en) * 1982-11-01 1984-04-17 The Salk Institute For Biological Studies Peptides affecting gonadal function
US4880778A (en) * 1986-05-12 1989-11-14 Eastman Kodak Company Combinations having synergistic growth hormone releasing activity and methods for use thereof
US4839344A (en) * 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
US4880777A (en) * 1987-09-01 1989-11-14 Eastman Kodak Company Synthetic peptides having growth hormone releasing activity
EP0400051B1 (en) * 1988-01-28 1995-05-10 Polygen Holding Corporation Polypeptide compounds having growth hormone releasing activity
US6737408B1 (en) 1997-08-07 2004-05-18 University Of Cincinnati Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
JP2003512303A (ja) * 1999-08-06 2003-04-02 ジェネンテック・インコーポレーテッド 因子ｖｉｉａのペプチドアンタゴニスト
US20040001827A1 (en) * 2002-06-28 2004-01-01 Dennis Mark S. Serum albumin binding peptides for tumor targeting
US20060228364A1 (en) * 1999-12-24 2006-10-12 Genentech, Inc. Serum albumin binding peptides for tumor targeting
EP1757311B1 (en) 1999-12-24 2009-02-11 Genentech, Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
AU784285B2 (en) 1999-12-24 2006-03-02 Genentech Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
US20050287153A1 (en) * 2002-06-28 2005-12-29 Genentech, Inc. Serum albumin binding peptides for tumor targeting
US7164002B2 (en) 2002-02-06 2007-01-16 Genentech, Inc. FVIIa antagonists
WO2005028498A2 (en) * 2003-09-18 2005-03-31 Raven Biotechnologies, Inc. Kid3 and kid3 antibodies that bind thereto
JP4390568B2 (ja) * 2004-01-19 2009-12-24 富士通株式会社 遅延測定システム
WO2005121179A2 (en) * 2004-06-07 2005-12-22 Raven Biotechnologies, Inc. Transferrin receptor antibodies
CA2583137A1 (en) * 2004-10-05 2006-04-20 Genentech, Inc. Therapeutic agents with decreased toxicity
EP1846767B1 (en) * 2005-01-12 2012-06-06 MacroGenics West, Inc. Kid31 and antibodies that bind thereto
WO2006083852A2 (en) * 2005-01-31 2006-08-10 Raven Biotechnologies, Inc. Luca2 and antibodies that bind thereto
US20060171952A1 (en) * 2005-02-02 2006-08-03 Mather Jennie P JAM-3 and antibodies that bind thereto
NZ556561A (en) * 2005-02-02 2011-08-26 Macrogenics West Inc Adam-9 modulators
JP5328156B2 (ja) 2005-02-03 2013-10-30 マクロジェニックス ウエスト， インコーポレイテッド オンコスタチンｍレセプターに対する抗体
US20070197445A1 (en) * 2006-01-18 2007-08-23 University Of Cincinnati Compounds for control of appetite
JP5601836B2 (ja) * 2006-11-08 2014-10-08 マクロジェニックス ウエスト， インコーポレイテッド Ｔｅｓ７およびｔｅｓ７に結合する抗体
EP2421549B1 (en) 2009-04-20 2013-06-12 Allergan, Inc. Silk fibroin hydrogels and uses thereof
PL219569B1 (pl) 2010-02-19 2015-05-29 Peptaderm Spółka Z Ograniczoną Odpowiedzialnością Cykliczne tetrapeptydy i ich zastosowanie
PH12012501751A1 (en) 2010-03-04 2012-11-12 Macrogenics Inc Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
MA34062B1 (fr) 2010-03-04 2013-03-05 Macrogenics Inc Anticorps réagissant avec b7-h3, fragments immunologiquement actifs associés et utilisations associées
SMT201900239T1 (it) 2011-05-21 2019-05-10 Macrogenics Inc Molecole di legame a cd3 in grado di legare cd3 umano e non umano
CN104011065B (zh) 2011-08-23 2017-06-30 哈佛大学校长及研究员协会 肽纳米粒子及其用途
US9487587B2 (en) 2013-03-05 2016-11-08 Macrogenics, Inc. Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
AU2014244286B2 (en) 2013-03-14 2018-11-08 Duke University Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor
EP2978438A1 (en) 2013-03-29 2016-02-03 Centre National de la Recherche Scientifique (C.N.R.S.) Cgrp receptor agonist for hiv treatment or prevention
ES2856839T3 (es) 2014-05-29 2021-09-28 Macrogenics Inc Moléculas de unión triespecíficas que se unen específicamente a múltiples antígenos del cáncer y métodos de uso de las mismas
US10717778B2 (en) 2014-09-29 2020-07-21 Duke University Bispecific molecules comprising an HIV-1 envelope targeting arm
CN107250161A (zh) 2015-01-26 2017-10-13 宏观基因有限公司 包含dr5‑结合结构域的多价分子
TWI773646B (zh) 2015-06-08 2022-08-11 美商宏觀基因股份有限公司 結合lag-3的分子和其使用方法
PL3328419T3 (pl) 2015-07-30 2021-12-27 Macrogenics, Inc. Cząsteczki wiążące pd-1 i sposoby ich zastosowania
JP7320944B2 (ja) 2015-10-08 2023-08-04 マクロジェニクス，インコーポレーテッド Ｂ７‐ｈ３に特異的に結合する分子及びｐｄ‐１に特異的に結合する分子
WO2017096017A1 (en) 2015-12-02 2017-06-08 Stsciences, Inc. Antibodies specific to glycosylated btla (b- and t- lymphocyte attenuator)
MA44082A (fr) 2015-12-14 2018-10-24 Macrogenics Inc Molécules bispécifiques présentant une immunoréactivité par rapport à pd-1 et à ctla-4 et leurs procédés d'utilisation
US10961311B2 (en) 2016-04-15 2021-03-30 Macrogenics, Inc. B7-H3 binding molecules, antibody drug conjugates thereof and methods of use thereof
US10111929B1 (en) 2017-04-07 2018-10-30 Ez Ip, Llc Growth hormone releasing factor analogs and uses
KR20220088428A (ko) 2019-09-26 2022-06-27 주식회사 에스티큐브앤컴퍼니 글리코실화된 ctla-4에 대해 특이적인 항체 및 이의 사용 방법
US20220356248A1 (en) 2019-10-09 2022-11-10 Stcube & Co Antibodies specific to glycosylated lag3 and methods of use thereof
US11596665B2 (en) 2020-06-23 2023-03-07 Chanda Zaveri Skin lightening formulations
US11951203B2 (en) 2020-08-26 2024-04-09 Chanda Zaveri Deep wrinkle vanishing compositions
US11793746B2 (en) 2020-10-01 2023-10-24 Chanda Zaveri Intense skin hydration systems and methods
US20220110852A1 (en) 2020-10-14 2022-04-14 Chanda Zaveri Pigment Stabilizers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904594A (en) * 1973-07-02 1975-09-09 Salk Inst For Biological Studi Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
US3842067A (en) * 1973-07-27 1974-10-15 American Home Prod Synthesis of(des-asn5)-srif and intermediates
US3917578A (en) * 1973-12-10 1975-11-04 Ayerst Mckenna & Harrison Process for producing somatostatin and intermediates
US3882098A (en) * 1974-01-03 1975-05-06 American Home Prod Synthesis of des-Ala{hu 1{b , Gly{hu 2{b , Asn{hu 5{b -SRIF and intermediates
US4011207A (en) * 1974-12-27 1977-03-08 American Home Products Corporation Des-(Ala1, Gly2,Lys4 -Srif, Des-(Ala1, Gly2, Lys4)-D-Trp8 -Srif and intermediates
US3933784A (en) * 1975-01-27 1976-01-20 American Home Products Corporation Des-(ser13)-srif and intermediates

Also Published As

Publication number Publication date
IE46862B1 (en) 1983-10-19
CA1102314A (en) 1981-06-02
IT7848586A0 (it) 1978-03-23
GB1564191A (en) 1980-04-02
US4105603A (en) 1978-08-08
ZA781599B (en) 1979-10-31
LU79320A1 (fr) 1978-06-29
FR2385688B1 (da) 1983-10-07
NL7803289A (nl) 1978-10-02
FI780907A (fi) 1978-09-29
SE446190B (sv) 1986-08-18
ES468241A1 (es) 1978-12-01
DE2813327C2 (da) 1988-08-18
JPS53130687A (en) 1978-11-14
AT366026B (de) 1982-03-10
DE2813327A1 (de) 1978-10-05
FR2385688A1 (fr) 1978-10-27
BE865380A (fr) 1978-07-17
ATA213878A (de) 1981-07-15
CH639361A5 (de) 1983-11-15
JPS6141920B2 (da) 1986-09-18
AU3430778A (en) 1979-09-27
IE780511L (en) 1978-09-28
AU519122B2 (en) 1981-11-12
SE7803318L (sv) 1978-09-29
IT1105152B (it) 1985-10-28

Similar Documents

Publication Publication Date Title
DK131878A (da) Fremgangsmaade til fremstilling af peptider og mellemprodukt til anvendelse ved fremgangsmaaden
DK421879A (da) Formstofnet og fremgangsmaade til fremstilling af dette
DK223478A (da) Fremgangsmaade ved sproejtestoebning og anlaeg til udoevelse af fremgangsmaaden
DK101078A (da) Falleroer og fremgangsmaade til fremstilling af samme
DK421979A (da) Formstofnet og fremgangsmaade til fremstilling af dette
DK353378A (da) Fremgangsmaade til fr&mstilling af phosphonoacylproliner og dermed beslagtede forbindelser
DK154945C (da) Antismuds- og antigenaflejringssammensaetning, fremgangsmaade til fremstilling og anvendelse af samme
DK155733C (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-oxo-pyrrolidinderivater
DK349478A (da) Fremgangsmaade til fremstilling af oligoimider
DK409780A (da) Fremgangsmaade til fremstilling af peptider
DK155279C (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-oxo-pyrrolidinderivater
DK275178A (da) Fremgangsmaade til fremstilling af lipopeptider og anvendelse deraf
NO152975C (no) Glyceroloksydase og fremgangsmaate til fremstilling derav.
DK180878A (da) Fremgangsmaade til fremstilling af imidazoaziner og imidazodiaziner
DK109478A (da) Fremgangsmaade til fremstilling af polypeptider
DK46578A (da) Klaebefri ionen-quaternaer polymer og fremgangsmaade til fremstilling af samme
DK292778A (da) Fremgangsmaade til fremstilling af peptider
DK313878A (da) Indolderivater og fremgangsmaade til fremstilling deraf
DK81380A (da) Fremgangsmaade til indramning
DK155780A (da) Fremgangsmaade til fremstilling af peptider
DK268478A (da) Mercaptoacylamidobenzoylglycin og fremgangsmaade til fremstilling deraf
DK328280A (da) Fremgangsmaade til fremstilling af 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazon og mellemprodukter herved
DK530978A (da) Fremgangsmaade til fremstilling af 3-jod- og 3-bromrifamycin s.
DK74578A (da) Fremgangsmaade til fremstilling af substituerede pyrroloquinoxalioner og pyrrolobenzodiazepioner
DK251178A (da) Fremgangsmaade til fremstilling af 9-hydroxyhexahydrodibenzo (b,d)pyraner og 1-substituerede -9-hydroxyhexahydrodibenzo (b,d)pyraner

Legal Events

Date Code Title Description
ARF Application refused